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f Aix Marseille Univ, Institut de Recherche pour le Developpement (IRD), Assistance Publique-Hôpitaux de Marseille, Evolution Phylogenie et Infections (MEPHI), Institut Hospitalo-Universi-
taire-Mediterranee Infection, Marseille, FranceKey Words:* Address correspondence to Saber Yezli, Global Cent
cine, Ministry of Health, Riyadh, Saudi Arabia.
E-mail address: saber.yezli@gmail.com (S. Yezli).
Funding/support: This work was sponsored by the Sa
Conflicts of interest: None to report.
https://doi.org/10.1016/j.ajic.2019.02.033Background: Data on the risk of transmission of infection to health care workers (HCWs) serving ill pilgrims 
during the Hajj is scarce.
Methods: Two cohorts of HCWs, the first serving Hajj pilgrims in Mecca and the second serving patients in 
Al-Ahsa, were investigated for respiratory and gastrointestinal symptoms and pathogen carriage using multi-
plex polymerase chain reaction before and after the 2015 Hajj.
Results: A total of 211 HCWs were enrolled of whom 92 were exposed to pilgrims (Mecca cohort), whereas 
119 were not exposed (Al-Ahsa cohort). Symptoms were observed only in HCWs from the Mecca cohort, 
with 29.3% experiencing respiratory symptoms during the Hajj period or in the subsequent days and 3.3%
having gastrointestinal symptoms. Acquisition rates of at least 1 respiratory virus were 14.7% in the Mecca 
cohort and 3.4% in the Al-Ahsa cohort (P = .003). Acquisition rates of at least 1 respiratory bacterium were 
11.8% and 18.6% in the Mecca and Al-Ahsa cohorts, respectively (P = .09). Gastrointestinal pathogens were 
rarely isolated in both cohorts of HCWs and acquisition of pathogens after the Hajj was documented in only 
a few individuals.
Conclusions: HCWs providing care for pilgrims both acquire pathogens and present symptoms (especially 
respiratory symptoms) more frequently than those not working during Hajj.Respiratory
Gastrointestinal
Carriagere for Mass Gatherings Medi-
udi Ministry of Health.Every year, approximately 2-3 million Muslims congregate in
Mecca, Kingdom of Saudi Arabia (KSA), to perform the Hajj.1 The
crowded conditions within a confined area and the close contact with
others, particularly during rituals, may lead to an increased risk of pil-
grims acquiring and spreading infectious diseases.2 Respiratory tract
infections (RTIs) are the most common infections transmitted among
pilgrims, and the majority of whom will develop RTI symptomsduring their few weeks in Saudi Arabia, mostly due to viral infection
and notably rhinovirus and influenza viruses.3,4 Cough attack rates
over 90% have been recorded among pilgrims from various nationali-
ties.4 Gastrointestinal infections, although less frequent than RTIs,
may also affect Hajj pilgrims. For instance, a diarrhea attack rate of
23% was observed in a cohort of French pilgrims.5
Each Hajj season, thousands of health care workers (HCWs) are
drafted from across the Kingdom to oversee and provide health care
during Hajj. This workforce may be at increased risk of acquiring
infection during the event. Although many studies regarding commu-
nicable disease during Hajj have been conducted in pilgrims, not
much has been conducted among HCWs. One study investigated
respiratory viruses among HCWs treating pilgrims during the 2009
Hajj and detected rhinovirus and coronavirus 229E in 12.6% and 0.6%
of the participants, respectively.6 Rhinovirus was detected in 21% of
those who had respiratory symptoms during Hajj.
Transmission of respiratory infections in controlled medical set-
tings is well known.7 However, the risk of acquisition and transmis-
sion of infections in such settings during the Hajj is even more
significant first, infected pilgrims returning from the Hajj may assist
in a wider spread outside the borders of the Kingdom, and second,
Hajj HCWs may serve as a vehicle to transmit infections to other hos-
pitals within the Kingdom on return to work post-Hajj. Today, this is
an even bigger concern in the context of the ongoing detection of
Middle East Respiratory Syndrome (MERS) coronavirus infections in
the Arabian Peninsula as a potential pandemic virus.8
This study was conducted with the aim to estimate the prevalence
of respiratory and gastrointestinal symptoms, as well as to determine
the acquisition of potential respiratory and gastrointestinal patho-
gens among HCWs attending pilgrims during the 2015 Hajj season
and comparing themwith HCWs not serving in Hajj.
METHODS
Participants and study design
Two cohorts of HCWs were investigated. The Mecca cohort
attended to the 2015 Hajj pilgrim patients at various hospitals at the
holy site of Mina, Mecca province, in Western KSA. These were: Mina
New Street Hospital, Mina Emergency Hospital, Mina Al-Jisr Hospital,
and Mina Al-Wadi Hospital. The Al-Ahsa cohort attended non-pilgrim
patients at various hospitals in Al-Ahsa in Eastern KSA approximately
1200 km from Mina. These were: King Fahad Hospital, Prince Sultan
Cardiac Center, and Prince Saud Ben Jalawi Hospital. HCWs were
asked to answer a standardized questionnaire that collected informa-
tion on demographics, vaccination status, and chronic conditions.
Information on symptoms during the Hajj and during the following 2
weeks were also collected.
Participants were asked to fill in the questionnaire and to provide
pre-Hajj (September 15, 2015 to September 20, 2015) and post-Hajj
(September 26, 2015 to October 4, 2015) samples. During the period
September 15, 2015 to October 4, 2015, HCWs were followed for the
development of respiratory or gastrointestinal symptoms. HCWs
were then followed-up by telephone (October 4, 2015 to November
4, 2015) to collect information regarding development of symptoms
in the 2 weeks after Hajj.
Respiratory and rectal specimens
Nasopharyngeal (NP) and rectal swabs were collected from each
participant before (September 15, 2015 to September 20, 2015) and
after the Hajj (September 26, 2015 to October 4, 2015) using commer-
cial rigid cotton-tipped swab applicators (Remel, Lenexa, KS), placed
in universal transport medium (Remel) at the time of collection and
stored in a −80°C freezer within 48 hours of collection. Respiratory
samples (NP swabs and sputum) and/or rectal swabs were also col-
lected from HCWs experiencing symptoms during Hajj, as appropri-
ate. The specimens were transported in dry ice to Aix-Marseille
University, France for analysis after the end of the sampling period.
Extraction of total nucleic acids
A 200-mL volume of sample was transferred to a 96 wells S-Bloc
(Qiagen, Venlo, Netherlands) for purification using the Cador Patho-
gen 96 QIAcube HT kit run on a QIAcube HT biorobot, according to
the manufacturer’s recommendations. Total nucleic acids were eluted
in 90 mL and stored at −80°C until processing.Detection of pathogens
All respiratory pathogens were tested using the FTD Respiratory
pathogens 33 and the FTD hCoV-EMC kits following manufacturer’s
recommendations (Launch Diagnostics Ltd, Kent, England) except for
Coxiella burnetii DNA, which detection was performed according to
previously described protocols.9
All enteric pathogens were tested using the FTD Viral gastroenter-
itis, the FTD Bacterial gastroenteritis, the FTD Stool parasites, and the
FTD EPA kits following manufacturer’s recommendations (Launch
Diagnostics Ltd), except for Tropheryma whipplei DNA and human
cytomegalovirus DNA, in which detection was performed according
to previously described protocols.10,11
Polymerase chain reaction (PCR) and reverse transcription-PCR
reactions were performed using CFX96 Biorad thermal cyclers (Bio-
Rad Laboratories, Inc., Hercules, CA).
STATISTICAL ANALYSIS
Characteristics of the study population were summarized as fre-
quencies and percentages for qualitative variables and as means,
range, and SDs for quantitative variables. Univariate analyses were
performed using the t test, the Pearson x2 test or the Fisher exact test,
as appropriate, to compare carriage and acquisition rates between
the 2 cohorts and to investigate the associations between clinical
symptoms and NP, and rectal pathogen carriage. All tests for signifi-
cance were 2-sided and P values <.05 were considered statistically
significant. All analyses were done using SPSS Version 21.0 (IBM
Corp, Armonk, NY) software program.
ETHICS
The study was approved by the King Fahad Medical City ethics
committee and the institutional review board. All participants were
informed about the study and consented to participate. The study
was conducted in accordance with the ethics committee guidelines
and good clinical practices recommended by the Declaration of Hel-
sinki and its amendments.
RESULTS
Demographics, vaccination status, and chronic medical conditions
A total of 211 HCWs were enrolled of whom 92 (43.6%) were
exposed to pilgrims (Mecca cohort), whereas 119 (56.4%) were not
exposed (Al-Ahsa cohort). Most HCWs were in the 20-40 year age
range (85.4%), were women (73.1%), non-Saudi (68.2%), and nurses
(77.8%) (Table 1). Over 60% of HCWs were immunized against menin-
gitis, but only 11.6% were vaccinated against invasive pneumococcal
disease. Immunization rate against influenza was 47% in 2015. Only
9.0% were current smokers and the prevalence of chronic conditions
was low (Table 1). Significant differences were observed between the
2 cohorts with those in Mecca being older, with a higher proportion
of men, Saudi nationals, and physicians compared with HCWs in the
Al-Ahsa cohort. Mecca HCWs were also more likely to be immunized
against meningitis and influenza and to be smokers (Table 1). No dif-
ferences in underlying health conditions were observed between the
two cohorts (Table 1).
Clinical symptoms
Clinical symptoms were reported only in HCWs from the Mecca
cohort, whereas HCWs from Al-Ahsa were all asymptomatic during
the study period. Clinical symptoms were reported in 31.5% (29 of
92) of the Mecca cohort, most of which (82.8%, 24 of 29) were
Table 1
Demographic and baseline characteristics of health care workers
Characteristic Mecca cohort
(n = 92)
Al-Ahsa cohort
(n = 119)
P value
Mean age, y (SD; age range) 35.3 (8.1; 24-64) 31.5 (7.3; 25-62) .001y
Age groups, Number (%)
20-40 years 68 (84.0) 96 (86.5)
41-60 years 11 (13.6) 14 (12.6)
>60 years 2 (2.5) 1 (0.9)
Sex, Number (%) <10¡3y
Male 46 (50.0) 10 (8.6)
Female 46 (50.0) 106 (91.4)
Nationality, Number (%) <10¡3y
Saudi 51 (60.7) 13 (11.1)
Non-Saudi 33 (39.3) 104 (88.9)
Occupation*, Number (%) .001y
Medical doctor 24 (27.3) 10 (8.7)
Nurse 56 (63.6) 102 (88.7)
Other 8 (9.1) 3 (2.6)
Vaccination status, Number (%)
Meningitis 81 (88.0) 47 (39.8) <10¡3y
Invasive pneumococcal disease 8 (15.1) 10 (9.8) .11
Influenza (2015) 59 (75.6) 20 (22.2) <10¡3y
Risk factors and chronic conditions, Number (%)
Smoking habit 17 (18.5) 2 (1.7) <10¡3y
Chronic respiratory disease 3 (3.3) 2 (1.7) .59
Chronic cardiac disease 2 (2.2) 0 2.64
Hypertension 4 (4.3) 2 (1.7) 1.34
Chronic kidney disease 1 (1.1) 0 1.34
Chronic gastrointestinal disease 2 (2.2) 0 2.64
Diabetes mellitus 3 (3.3) 3 (2.5) .11
Cancer 0 0 -
Immune deficiency 1 (1.1) 0 1.33
*Medical doctor versus other.
yStatistically significant difference.reported only post-Hajj. Four HCWs experienced symptoms only dur-
ing the Hajj and 1 during and after the Hajj. HCWs experienced symp-
toms lasting between 2 and 15 days. Nearly 30% (27 of 92) of HCWs
from the Mecca cohort experienced respiratory symptoms during the
Hajj period and up to 2 weeks after the event, and 3 (3.3%) reported
gastrointestinal symptoms (Table 2). Fever, cough, and sore throat
were the most common symptoms reported in respectively 15.2%,
18.5%, and 14.1% of the Mecca cohort HCWs during the study period.Table 2
Clinical symptoms of health care workers during the study period
Characteristic Mecca cohort*
(n = 92)
Al-Ahsa cohort
(n = 119)
Fever 12 (13.0) 0
Headache 2 (2.2) 0
Respiratory symptoms
Cough 14 (15.2) 0
Sore throat 12 (13.0)) 0
Runny nose 5 (5.4) 0
Voice failure 0 0
Dyspnea 1 (1.1) 0
Chest pain 0 0
Sputum 4 (4.3) 0
At least 1 respiratory symptom 27 (29.3) 0
Gastrointestinal symptoms
Nausea 1 (1.1)) 0
Vomiting 0 0
Diarrhea 3 (3.3) 0
Abdominal pain 2 (2.2) 0
At least 1 gastrointestinal symptom 3 (3.3) 0
*Five health care workers reported symptoms during the Hajj (1 had dyspnea, nausea,
diarrhea, and abdominal pain; 1 had rhinitis, diarrhea, and abdominal pain; 1 had
cough, sore throat, and headaches; 1 had rhinitis, sore throat, and sputum; 1 had
cough, sputum, rhinitis, sore throat, and headaches).Detection of pathogens in respiratory and rectal samples
The median time between pre- and post-Hajj sampling was
11 days (range 8-18 days). At least 1 respiratory virus was isolated in
13.5% of pre-Hajj samples in the Mecca cohort, compared to 4.2% in
the Al-Ahsa cohort (Table 3). The overall prevalence of respiratory
virus carriage increased to 21.1% in post-Hajj samples in the Mecca
cohort, whereas it did not change in the Al-Ahsa cohort (4.2%). Post-
Hajj respiratory carriage was significantly higher in the Mecca cohort
compared to the Al-Ahsa cohort (P < 10¡3). Acquisition rates of at
least 1 respiratory virus were respectively 14.7% in the Mecca cohort
and 3.4% in the Al-Ahsa cohort (P = .003).
Rhinovirus accounted for the majority of positive samples, and its
prevalence was significantly higher in post-Hajj samples (19.7%) com-
pared with pre-Hajj samples (6.7%) in the Mecca group (P = .014),
whereas no significant differences were observed in the Al-Ahsa
group (3.4% vs 2.5%; P = .72). Rhinovirus acquisition rate in the Mecca
cohort (16.2%) was significantly higher than in the Al-Ahsa cohort
(2.5%) with P = .001.
At least 1 respiratory bacterium was isolated in 32.6% of pre-Hajj
samples in the Mecca cohort, compared to 37.0% in the Al-Ahsa
cohort (Table 3). Compared with pre-Hajj samples, no significant dif-
ferences were observed in the overall prevalence of respiratory bacte-
rial carriage in post-Hajj samples in both cohorts (28.2% and 36.4%,
respectively). Acquisition rates of at least 1 respiratory bacterium
were respectively 11.8% in the Mecca cohort and 18.6% in the Al-Ahsa
cohort (P = .09).
Staphylococcus aureus and Klebsiella pneumoniae accounted for the
majority of positive cases either in pre- or post-Hajj samples. In the
Al-Ahsa cohort, the prevalence of Staphylococcus aureus significantly
increased from 12.6% before the Hajj to 33.9% after the Hajj (P <
10¡3), whereas the prevalence of K pneumoniae significantly
Table 3
Prevalence of respiratory pathogens among health care workers before and after the 2016 Hajj
Mecca cohort Al-Ahsa cohort
Respiratory Pathogens Before Hajj (n = 89)
Number (%)
After Hajj (n = 71)
Number (%)
P value Before Hajj (n = 119)
Number (%)
After Hajj (n = 118)
Number (%)
P value
Viruses
Influenza virus C 1 (1.1) 0 (0.0) 1 0 (0.0) 0 (0.0) -
Human coronavirus 229E 1 (1.1) 0 (0.0) 1 1 (0.8) 0 (0.0) 1
Human coronavirus NL63 2 (2.2) 0 (0.0) .50 0 (0.0) 1 (0.8) .50
Human coronaviruses 3 (3.4) 0 (0.0) .25 1 (0.8) 1 (0.8) 1
Human enterovirus 0 (0.0) 1 (1.4) .44 0 (0.0) 0 (0.0) -
Human metapneumovirus 2 (2.2) 0 (0.0) .50 0 (0.0) 0 (0.0) -
Human parainfluenza virus 4 0 (0.0) 0 (0.0) - 1 (0.8) 1 (0.8) 1
Human parainfluenza viruses 0 (0.0) 0 (0.0) - 1 (0.8) 1 (0.8) 1
Human respiratory syncytial virus 0 (0.0) 1 (1.4) .44 0 (0.0) 0 (0.0) -
Human rhinovirus 6 (6.7) 14 (19.7) .014y 3 (2.5) 4 (3.4) .72
Other viruses* 0 (0.0) 0 (0.0) - 0 (0.0) 0 (0.0) -
At least 1 virus 12 (13.5) 15 (21.1) .20 5 (4.2) 5 (4.2) 1
Bacteria and fungi
Haemophilus influenzae 2 (2.2) 3 (4.2) .66 5 (4.2) 2 (1.7) .45
Klebsiella pneumoniae 8 (9.0) 10 (14.1) .31 21 (17.6) 4 (3.4) <10¡3y
Moraxella catarrhalis 1 (1.1) 2 (2.8) .58 1 (0.8) 1 (0.8) 1
Staphylococcus aureus 17 (19.1) 10 (14.1) .40 15 (12.6) 40 (33.9) <10¡3y
Streptococcus pneumoniae 2 (2.2) 1 (1.4) 1 7 (5.9) 1 (0.8) .066
Other bacteria and fungiz 0 (0.0) 0 (0.0) - 0 (0.0) 0 (0.0) -
At least 1 bacteria or fungi 29 (32.6) 20 (28.2) .55 44 (37.0) 43 (36.4) .53
*Influenza virus A/H3N2, influenza virus B, influenza virus 2009 A (H1N1), human adenovirus, human bocavirus, human coronavirus HKU1, human coronavirus OC43, Middle East
Respiratory Syndrome coronavirus, human cytomegalovirus, human parainfluenza virus 1, human parainfluenza virus 2, human parainfluenza virus 3, human parechovirus.
yStatistically significant difference.
zBordetella pertussis, Chlamydia pneumoniae, Coxiella burnetii, Legionella spp,Mycoplasma pneumoniae, Pneumocystis jirovecii, Salmonella spp.decreased from 17.6% pre-Hajj to 3.4% post-Hajj (P < 10¡3). Staphylo-
coccus aureus acquisition rate was 5.9% in the Mecca cohort compared
to 26.3% in the Al-Ahsa cohort (P = .002). K pneumoniae acquisition
rate was 10.3% in the Mecca cohort compared to 1.7% in the Al-Ahsa
cohort (P = .018). No significant effect of tobacco smoking, chronic
medical conditions, and vaccination status was observed on the
acquisition rates of respiratory viruses in the Mecca cohort. No statis-
tically significant association was observed between respiratory path-
ogen carriage and clinical symptoms in the Mecca cohort.
Enteric pathogens were rarely isolated in both cohorts of HCWs,
and acquisition of pathogens after the Hajj was documented in only a
few individuals (Table 4). Of note, Clostridium difficilewas acquired byTable 4
Prevalence of rectal pathogens among health care workers before and after the 2016 Hajj
Mecca cohort
Rectal Pathogen Before Hajj (n = 53)
Number (%)
After Hajj (n = 3
Number (%)
Viruses
Adenovirus 0 (0.0) 0 (0.0)
Norovirus G1 0 (0.0) 0 (0.0)
Other viruses* 0 (0.0) 0 (0.0)
Bacteria
Clostridium difficile 0 (0.0) 1 (2.7)
Verocytotoxin-producing Escherichia coli 0 (0.0) 1 (2.7)
Salmonella spp 0 (0.0) 0 (0.0)
Tropheryma whipplei 1 (1.9) 0 (0.0)
Other bacteriay 0 (0.0) 0 (0.0)
Protozoa
Giardia lamblia 1 (1.9) 0 (0.0)
Other protozoaz 0 (0.0) 0 (0.0)
At least 1 pathogen 2 (3.8) 2 (5.4)
*Astrovirus, Enterovirus, Norovirus G2, Parechovirus, Rotavirus, Sapovirus.
yCampylobacter coli, Campylobacter jejuni, Campylobacter lari, Enteroinvasive Escherichia coli, S
zCryptosporidium spp, Entamoeba histolytica.1 HCW in the Mecca cohort, and Tropheryma whipplei by 2 HCWs in
the Al-Ahsa cohort. No statistically significant association was
observed between rectal pathogen carriage and clinical symptoms in
both cohorts.
Pathogens detected during the Hajj episodes among HCWs with
symptoms
Five HCWs in the Mecca cohort were sampled at the onset of
symptoms during the Hajj. One was positive for Haemophilus influen-
zae, 1 had a dual infection with rhinovirus/H influenzae, 1 with rhino-
virus/K pneumoniae, and 2 were negative.Al-Ahsa cohort
7) P value Before Hajj (n = 110)
Number (%)
After Hajj (n = 117)
Number (%)
P value
- 1 (0.9) 0 (0.0) .48
- 0 (0.0) 1 (0.9) 1
- 0 (0.0) 0 (0.0) -
.41 0 (0.0) 0 (0.0) -
.41 3 (2.7) 0 (0.0) .112
- 1 (0.9) 0 (0.0) .48
1 1 (0.9) 3 (2.6) .62
- 0 (0.0) 0 (0.0) -
1 0 (0.0) 0 (0.0) -
- 0 (0.0) 0 (0.0) -
1 6 (5.5) 4 (3.4) .53
higella spp, Yersinia enterocolitica.
DISCUSSION
Previous studies addressing the prevalence of respiratory infec-
tion in Hajj HCWs are scant. In a study conducted among 250 person-
nel (25.6% of whom were physicians or nurses) serving at 2 Hajj
mission hospitals during the 2004 season, a 22.6% attack rate of acute
respiratory infections during and after the Hajj was observed with
acute respiratory infections defined by the association of at least 1
constitutional symptom (fever, headaches, and myalgia) and at least
1 respiratory symptom.12 In a study conducted among 120 HCWs
from the Saudi Ministry of Health (MOH) and other Hajj medical mis-
sions during the 2009 season, 10.6% reported respiratory symptoms
during the Hajj, and 12.5% were found infected by at least 1 virus
post-Hajj comparing to 7.5% pre-Hajj using a PCR assay.6 All positive
cases were due to rhinovirus, but 1 post-Hajj case was due to corona-
virus 229E.6
We confirm in the current work that HCWs attending ill Hajj pil-
grims present frequently with respiratory symptoms (29%) during
and soon after the Hajj period. Additionally, we show that diarrhea is
rare (3%). Such symptoms were not observed in another cohort of
HCWs attending non-pilgrim patients in another region of Saudi Ara-
bia during the same period of time. HCWs attending pilgrims
reported symptoms that lasted up to 2 weeks. No symptomatic HCWs
reported loss of workdays during the Hajj in our study, and the num-
ber of sick days because of illness post-Hajj was not recorded. Never-
theless, illness during or post-Hajj among HCWs does not only affect
the wellbeing of the HCWs involved, but may also have an impact on
work productivity, delivery of health care services, as well as poten-
tially an economic cost. This is especially relevant during Hajj when
the health care system is under a significant amount of stress and
operating at near surge capacity in many Hajj areas. Numerous stud-
ies reported that employee absence is related to decreased job pro-
ductivity and important economic costs including in the health care
sector.13-15 Further studies are needed for a better understanding of
the impact of Hajj-related illness among HCWs.
Although no correlation was observed between clinical symptoms
and detection of respiratory pathogens, we report that HCWs
exposed to ill pilgrims carried and acquired a number of respiratory
pathogens including acquisition of rhinovirus, enterovirus, respira-
tory syncytial virus, H influenzae, K pneumoniae, Moraxella catarrhalis,
Staphylococcus aureus, and Streptococcus pneumoniae. These organ-
isms have been shown to also be commonly carried by and transmit-
ted among Hajj pilgrims.16-18 Significant acquisition of rhinovirus in
superior airways of Mecca HCWs was recorded at a rate of 16.2%,
whereas the acquisition rates of the 2 most frequently detected bac-
terial pathogens (K pneumoniae and Staphylococcus aureus) among
this cohort were 10.3% and 5.9%, respectively. In a carriage study
among pilgrims from 13 countries in 2013 Hajj, acquisition rates of
rhinovirus, K pneumoniae, and Staphylococcus aureus were 34.1%,
3.9%, and 7.5%, respectively.19 Influenza A and B viruses were not iso-
lated, which may be owing to the relatively high rate of influenza vac-
cination, notably in the Mecca cohort (76%). Lower rates of influenza
vaccination were recorded among Hajj HCWs in 2003 (6%) and 2009
(35%).19,20 Streptococcus pneumoniae carriage was documented in a
few HCWs, notably in the Al-Ahsa cohort, in which the vaccination
rate against invasive pneumococcal disease was low (10%).
No MERS coronavirus was identified in HCWs either before or
after Hajj. This is in accordance with previous reports showing lack of
MERS coronavirus carriage and infection among Hajj pilgrims.21-26
Acquisition and carriage of potentially pathogenic organisms by
HCWs do not only constitute a risk for development of disease by the
HCWs carriers themselves, but also a risk of transmission and infection
of the vulnerable patients they care for. The role of HCWs as a vector
for nosocomial infections is well established,27,28 especially in relation
to RTIs.27 Therefore, effective infection prevention and control (IPC)strategies in health care settings to reduce the likelihood of infection
among HCWs and patients are crucial in the Hajj context. As such, the
Saudi MOH has a strict IPC training and educational program for HCWs
deployed for Hajj, beyond the standard training programs these HCWs
undertake throughout the year in their own health care facilities across
the Kingdom. This is because HCWs deployed during Hajj come from a
wide range of health institutions in KSA with diverse backgrounds on
IPC measures. Some may be stationed at seasonal hospitals in the
Mecca holy sites that are only operational during Hajj and will be pro-
viding care to pilgrims originating from all over the world. Therefore,
since 2016, the Saudi MOH requires all HCWs deployed during Hajj to
complete training to acquire a basic infection control skills license
(BICSL). The latter involves 5 basic components: proper hand hygiene,
proper use of personal protective equipment, application of the N95 fit
test, principles of safe injection practice, as well as compulsory influ-
enza and meningococcal vaccination. For the 2017 Hajj, 14,029 HCWs
were trained for the BICSL representing 100% of the targeted number
to be trained.29
The Kingdom also ensures that health care centers and hospitals
providing services for pilgrims are equipped with the necessary facili-
ties for infection prevention. During the 2017 Hajj, 403 isolation
rooms, 168 negative pressure rooms, and 461 high efficiency particu-
late air filters were available at the Hajj health care facilities.29 The
Saudi MOH also has developed and published various IPC policies,
including those specifically for Hajj, to help HCWs develop their
knowledge and skills in the area and adhere to best practices. In addi-
tion, various trainings and drills are conducted pre-Hajj for HCWs as
per their function and in relation to a number of possible infectious
risks such as MERS. Awareness campaigns are also part of the IPC pro-
gram for HCWs during Hajj, especially in relation to the importance of
immunization, food and safety hygiene standards, and general IPC
practices that go hand-in-hand with those awareness campaigns
aimed at pilgrims, holy cities residents, and non-HCWs.
Our results indicate that there is a need for better adherence to
immunization policies, especially in relation to influenza vaccination
for all HCWs and meningococcal vaccination for those deployed to
Hajj. Due to various initiatives by the Saudi MOH, rates of influenza
vaccination among HCWs in KSA are high in recent years.30,31 Never-
theless, we found low influenza vaccination rates among HCWs not
deployed to Hajj in 2015. One possible contributor to this finding is
that the influenza vaccination season in KSA for HCWs not deployed
to Hajj runs from September to March. Given that our data collection
was conducted mid-September, it is possible that a number of HCWs
from the Al-Ahsa cohort did not yet receive their influenza vaccina-
tion at the time of the study. For HCWs deployed in Hajj, the rates of
immunization in our study were similar to those reported in a study
conducted in the 2015-2017 Hajj seasons.32 However, our data indi-
cates that the rate of immunization of influenza vaccination among
the Hajj cohort was higher than that reported pre-2015.19,20 In gen-
eral, since the introduction of the compulsory BICSL license that
includes the compulsory influenza and meningococcal immunization
section, data from the MOH indicate that in 2017, all HCWs deployed
to Hajj were vaccinated with both vaccines.
Our study has some limitations. Although we enrolled an ade-
quate number of HCWs in both cohorts and had a good follow-up
rate, the number represents a small fraction of the thousands of
HCWs deployed for Hajj. Therefore, our results may not be generaliz-
able to all HCWs working during Hajj and in all specialties. Also, data
on the number of days off work due to sickness among HCWs post-
Hajj was not collected, and that would have given a better picture of
the burden of illness associated with Hajj deployment for HCWs and
the health system at large. Finally, although we aimed to match the
Al-Ahsa cohort with our Mecca cohort in terms of health care facilities
size, type of patients, and other factors, given the specific nature of
the Hajj, it was impossible to completely match the two cohorts.
CONCLUSIONS
We conducted the first study to investigate illness and carriage of
respiratory and gastrointestinal pathogens among HCWs during Hajj.
We found that HCWs providing care for pilgrims both acquire patho-
gens and present symptoms (especially respiratory symptoms) more
frequently than those not working during Hajj. The Kingdom has a
strict IPC awareness, training, and education program for HCWs
deployed for Hajj each year, in conjunction with compulsory influ-
enza and meningococcal vaccination and provision of IPC facilities,
and equipment to reduce the risk of transmission and illness among
both HCWs and patients during the event. The Kingdom has also the
capacity to deploy extra HCWs for Hajj in times of need. Nevertheless,
strict adherence to IPC policies and guidelines among HCWs, espe-
cially in relation to preventing respiratory infections, and continuous
monitoring, feedback, and improvement of IPC strategies for Hajj are
needed. This to preserve the health and wellbeing of HCWs working
during Hajj, to protect the patients they care for and to prevent
potential workdays and economic loss resulting from HCWs illness
either during or post-Hajj.References
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